{"name":"Vigil Neuroscience","slug":"vigil","ticker":"VIGL","exchange":"NASDAQ","domain":"vigilneuro.com","description":"Vigil Neuroscience is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. The company's lead product, Vigilanz, is a small molecule inhibitor of the Wnt/β-catenin pathway, which is implicated in the pathogenesis of several neurodegenerative diseases. Vigil Neuroscience has a strong pipeline of preclinical and clinical-stage programs, and its products have the potential to address significant unmet medical needs in the neuroscience market.","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"Ivana Magovcevic-Liebisch","sector":"Neuroscience / Neurodegeneration","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$180M","metrics":{"revenue":2000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":62306000,"netIncome":-84256000,"cash":117691000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"Vigilanz patent cliff ($0.0B at risk)","drug":"Vigilanz","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Vigil Neuroscience reported its fourth quarter and full year 2023 financial results, with a net loss of $23.4 million for the year.","drugName":"","sentiment":"neutral"},{"date":"2023-06-15","type":"deal","headline":"Vigil Neuroscience Announces Collaboration with Biogen to Develop Treatments for Neurodegenerative Diseases","summary":"Vigil Neuroscience announced a collaboration with Biogen to develop treatments for neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNaXFIVHdtZGgwcUo1ZnJxbFVjQ1JGUnpwYmpndjhLTS10ZW5nN3RzZ0U0UUhhaE9RMUcteUJReS10QkM2SFF2bXBidzFpQnhNLXZ4ejVDQ09sSGdFVEdNTHROQ016aU1tNDFMQ1A3WGd4Y1p1ckkyUWw0NW9UQ3JxOFBtTzMtNG12XzVJWlNHemhiR1Qzd1dyMzRMVmR2RWtVNFo3VkdPMWkxeThkZmY3Yl82OVI?oc=5","date":"2025-06-02","type":"pipeline","source":"Investopedia","summary":"Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover - Investopedia","headline":"Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNREg1NVVia1dDbGFxLVgyZzJLMVNodTVScmVFSFVDb09hS05Ca0pqRUtqNWJJX3pYZldhdWdCSVAzLVM2Yk04UDBQeEQxbUQ2NFF4ZEdvS2ZwQmN0eWYzRllXMWZEaHh1ZFlQaXEwR1BkN1V4ejNmZVJLUVBVSHJOelJOU2ZxSzVPb0xVNlFjWXhrTS1p?oc=5","date":"2025-05-23","type":"pipeline","source":"The Business Journals","summary":"Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug - The Business Journals","headline":"Sanofi to spend $470M for Watertown biotech’s Alzheimer’s drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBGSHpDSUdBSlVXVmYzT3F1ZDhQQVZrank1U0g0cmRnd2R3b3Y0Y2hNMk5VeWVyN0hLbXd0OG9Wd0RZQ2oyX1QwYm5kUWo0YXo0NzBwVWJnQjhCNU56amdSU0FsZE5RVHVFeTUwZVh0Y0syM2ZvbFNXWm1GVEZjYlE?oc=5","date":"2025-05-23","type":"deal","source":"Yahoo Finance","summary":"Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More - Yahoo Finance","headline":"Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQdG5XeEUzUzZld1p4eU12aTBKTjl5NXdlQ09xdW5GaFJzZDVsV196R2NSLVBacUozT1FBV2J1SlVsNU1DQ2l3ZEItbnNJSzdkdXlBaVBpMURXZGQyWk82d0FfNl8tUHBoclpId0dzYmtfZGJlT1htUWVGNmIzM1JiUENLc09IV1JWamZTd0ZISnpjQmNjTFVnSFNHNmJhVk5ZZGVZWndJZlNlSmdVcTdLTW9rNG1zdw?oc=5","date":"2025-05-22","type":"pipeline","source":"Investopedia","summary":"Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi - Investopedia","headline":"Vigil Neuroscience Stock Triples as Drugmaker Agrees to Acquisition by Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPYnM1MkVLUldVS3hBQm5ScEY4YTNPQnEwaG9BUFN2QlF5U1h0SWFpdEcwN0hBbzB6QTczN1RmQTY0eGhtekkwemRnTEtJVVNvekczSm45QUEzOHpYaWtBSmI2T0pVSURSZGJjZ2U4U2dYRGxWVlYwZU1GVkFRT0xFaDMxRlZ4ZkdlQWg3VGdILVVHMU90V3ZyOVVCSmFLcGl4NG9hazNqRXVoTkxMa25Wc3pMSUNKb2Q2R2hXaDFHOF9KUQ?oc=5","date":"2025-05-22","type":"pipeline","source":"MedCity News","summary":"Sanofi’s Neuro Pipeline Expands to Alzheimer’s With $470M Vigil Neuroscience Acquisition - MedCity News","headline":"Sanofi’s Neuro Pipeline Expands to Alzheimer’s With $470M Vigil Neuroscience Acquisition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQaHZRRlpMdkZLUWdvUGRkQWFJTWNqTTNaVTZrRFN2WnF6QUtoVUZ6T3QzWExYbzdKVUR0djZzbjVlNEpROEFVZmNkTTlrTXdrNkJTQ1k5RnRSbllZMDRLN3k2UXN6UFBxV2dqRW8tV2F6ckRobHJXSnpsek54MklEckxyZl9jRU40bFpLVlI0eHJXTWZ1VXdYMGZNUTRHUQ?oc=5","date":"2025-05-21","type":"deal","source":"WSJ","summary":"Sanofi to Buy Vigil Neuroscience for About $470 Million - WSJ","headline":"Sanofi to Buy Vigil Neuroscience for About $470 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNVGY2LUVsUG1IX09takM4Sk1KM2NCZ21rNU5kQVRMLWhtbUhqNXFJUHhvQm83OUU1NHMtdEtsNi0tWHRnTl9PalNNUFFoaWhLbXJPazN2STBQcVFlS0lrTmM4d0VaQm5jR2VoaXR6MXVla29ZT1NCaFNEZnAzZU9SVDI5aVhxLTBsdXEtQXFoUGgxUW8?oc=5","date":"2025-05-21","type":"deal","source":"Yahoo Finance","summary":"Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi - Yahoo Finance","headline":"Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1fMDhPQlBBeU1HV01hTmt6SEZtLVRmamV6NW1aUlZmU0g1RlAwOVdjNW03aVdZdDZiU1VGRmJoOFFqblhCSGxfUS1qWXppQnhxVzhN?oc=5","date":"2025-04-24","type":"pipeline","source":"Stock Titan","summary":"VIGL Stock Price, News & Analysis - Stock Titan","headline":"VIGL Stock Price, News & Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQNmx4YzNYMi1ZN2VfaVZ0YWcyVFBLY05FQURJbVN2eGFLMUJ3UHEwem9udkFTbmJFeS1aRTRFWlBuMUw1aF9yUWxkOWZUS0J2amJLcG9RMjVwMGdqUGxNZG5CaGg2a2tEMFJnMnBQZDlSVE1hVTZxX1lzbVZyMVJxai14X21jVXJrdXM3SEhKX2Q?oc=5","date":"2024-12-03","type":"pipeline","source":"Seeking Alpha","summary":"Vigil Neuroscience: Down On A Competitor's Failure (NASDAQ:VIGL) - Seeking Alpha","headline":"Vigil Neuroscience: Down On A Competitor's Failure (NASDAQ:VIGL)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE5iblhtYXI3U0NVbEI1Tk1DS0N6RU9nNXhLbklvWHQzbUEwbk5DWEFSQjh4UU4xRndqeGZnUXhZNkx5VDltWlFFb3BaTEZpNUZ4anVrTHFqVUVkZw?oc=5","date":"2022-01-08","type":"pipeline","source":"MarketBeat","summary":"Vigil Neuroscience (VIGL) Stock Price, News & Analysis $VIGL - MarketBeat","headline":"Vigil Neuroscience (VIGL) Stock Price, News & Analysis $VIGL","sentiment":"neutral"}],"patents":[{"drugName":"Vigilanz","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Biogen","Eli Lilly and Company","Pfizer Inc."],"therapeuticFocus":["Neurodegeneration","Alzheimer's disease","Parkinson's disease"],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":62306000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-84256000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":117691000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}